Sebastien Verhenne
Kortrijk, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
von Willebrand factor increases in experimental cerebral malaria but is not essential for late-stage pathogenesis in mice.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 31, 2019
A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A.
Journal: Thrombosis and haemostasis
Published: October 23, 2019
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors.
Journal: EMBO molecular medicine
Published: August 14, 2019
von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 10, 2019
High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 27, 2017
Improved molecular platform for the gene therapy of rare diseases by liver protein secretion.
Journal: European journal of medical genetics
Published: September 07, 2017
Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 28, 2016
ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Journal: Expert review of hematology
Published: November 20, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026